ABVC BioPharma, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-151.0K | $144.3K |
| FY2020 | — | $3.4M | $4.3M |
| FY2021 | — | $8.8M | $5.8M |
| FY2022 | — | $3.1M | $85.3K |
| FY2023 | — | $1.6M | $60.2K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-151.0K | $144.3K |
| FY2020 | — | $3.4M | $4.3M |
| FY2021 | — | $8.8M | $5.8M |
| FY2022 | — | $3.1M | $85.3K |
| FY2023 | — | $1.6M | $60.2K |